| Date | Form | Description | Docs | XBRL | Pages |
| 06/02/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/27/21 | 8-K | Current report filing |
|
9 | |
| 05/04/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/23/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Read More...